Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Clinical trial NCT07225972 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07225972
Sponsor: New York Medical College
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

CMV AdV Infection AdV Reactivation Adenovirus Cytomegalovirus Infections

Start date: 2026-12-01
Primary completion: 2031-12-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.